Figure 4
Figure 4. Platelets must have CD154 for collagen-mediated CTL augmentation. (A) CD154−/− mice were immunized subcutaneously on the flank with 106 pfu Ad5-mOVA in PBS or 30 mg/mL collagen. After 14 days, spleens were harvested for lytic assays. (B) CD154−/− mice were adoptively transferred with 3 × 108 B6 platelets 4 hours before subcutaneous immunization with 106 pfu Ad5-mOVA in PBS or 30 mg/mL collagen on the flank. After 14 days, spleens were harvested for lytic assays. Each panel is representative of 2 experiments of 3 mice per group.

Platelets must have CD154 for collagen-mediated CTL augmentation. (A) CD154−/− mice were immunized subcutaneously on the flank with 106 pfu Ad5-mOVA in PBS or 30 mg/mL collagen. After 14 days, spleens were harvested for lytic assays. (B) CD154−/− mice were adoptively transferred with 3 × 108 B6 platelets 4 hours before subcutaneous immunization with 106 pfu Ad5-mOVA in PBS or 30 mg/mL collagen on the flank. After 14 days, spleens were harvested for lytic assays. Each panel is representative of 2 experiments of 3 mice per group.

Close Modal

or Create an Account

Close Modal
Close Modal